Main Second Level Navigation
Breadcrumbs
- Home
- About Us
- Our Research Leadership
Our Research Leadership
Executive Director
Lorraine Lipscombe, MDCM, MSc, FRCPC
Dr. Lorraine Lipscombe is a Professor in the Department of Medicine and the Dalla Lana School of Public Health at the University of Toronto, as well as a clinician scientist and endocrinologist at Women’s College Hospital. Dr. Lipscombe is also the Executive Director of the University of Toronto’s Novo Nordisk Network for Healthy Populations, which is a cross-disciplinary research network that aims to address the burden of diabetes and other chronic diseases with a focus on the Ontario Region of Peel.
Dr. Lipscombe received her MD from McGill University, followed by training in Internal Medicine and Endocrinology and a Master’s in Clinical Epidemiology, at University of Toronto. Dr. Lipscombe leads an internationally recognized research program in diabetes epidemiology and health services, with a particular focus on health services for the management and prevention of diabetes in women. She has published over 150 peer-reviewed articles, and has held numerous grants and career awards from CIHR and Diabetes Canada, where she currently serves on the Board of Directors.
Novo Nordisk Research Chair in Equitable Care of Diabetes and Related Conditions
Baiju Shah, MD, PhD
Dr. Baiju Shah is a health services researcher and clinician-scientist in endocrinology. He is a staff physician and Head of the Division of Endocrinology at Sunnybrook Health Sciences Centre, and a Scientist at the Sunnybrook Research Institute. He is a Professor in the Department of Medicine and the Institute of Health Policy, Management and Evaluation at the University of Toronto, and a Senior Core Scientist at ICES. His research seeks to understand and improve the quality of care and long-term outcomes of people with diabetes. He has national and international leadership in several areas of research, including diabetes care in immigrant, indigenous and other disadvantaged populations; long-term cardiometabolic consequences for women following gestational diabetes; and novel models of healthcare delivery to improve outcomes.
Novo Nordisk Research Professor in Health Equity of Chronic Illness Prevention
Hailey Banack, PhD
Dr. Hailey Banack is an Assistant Professor in Epidemiology in the Dalla Lana School of Public Health at the University of Toronto. Her research focuses on obesity and aging. She is interested in novel measurement approaches for body composition in older adults and understanding age-related change in body composition among women and individuals from racial/ethnic minority groups. She has a particular interest in epidemiologic methods, including quantitative bias analysis and causal inference. Dr. Banack currently has two large NIH-funded grants (R37CA258761 and R01AG078249) focused on chronic disease outcomes (cancer, diabetes) in postmenopausal women. She is also a co-investigator with the longstanding Women’s Health Initiative (WHI) study, a prospective cohort of postmenopausal women that has been ongoing for >30 years. In addition to her program of research, Dr. Banack enjoys teaching epidemiology and is the co-host of a podcast called SERious Epi. The SERious Epi podcast is aimed at trainees and practicing epidemiologists who want to learn more about study design and analytic approaches used in epidemiology.